Similares a One Year of Brensocatib: How Bronchiectasis Care Has Changed

20 vecinos (text_768) · 399 views · HCPLive · Estados Unidos


★	One Year of Brensocatib: How Bronchiectasis Care Has Changed	HCPLive @hcplivenews	399	Estados Unidos
2	Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients \| ATS 2026	HCPLive @hcplivenews	1.2K	Estados Unidos	84
10	Diabetes Dialogue: FDA Approves Afrezza Inhaled Insulin for Pediatric Patients	HCPLive @hcplivenews	683	Estados Unidos	83
9	What #Allergists Should Know About Broncho-Vaxom for Respiratory Tract Infection	HCPLive @hcplivenews	348	Estados Unidos	83
14	Novo Nordisk's Wegovy gets a boost in the U.K.	Quartz @qznews	292	Estados Unidos	83
6	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	84
19	Atacicept Approval Brings BAFF/APRIL Targeting to IgAN With Richard Lafayette, MD	HCPLive @hcplivenews	173	Estados Unidos	83
12	Wednesday's Daily Dose: A new mRNA flu vaccine, robotic surgery milestone and lung cancer screening	WKYC Channel 3 @wkycchannel3	170	Estados Unidos	83
3	Afrezza’s Pediatric Approval and Improving Adolescent Diabetes Care	HCPLive @hcplivenews	160	Estados Unidos	84
5	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	156	Estados Unidos	84
7	REACH Study: Broncho-Vaxom (OM-85) Cuts Recurrent Respiratory Tract Infections	HCPLive @hcplivenews	134	Estados Unidos	84
11	Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease \| ATS 2026 With Gerard Criner, MD	HCPLive @hcplivenews	113	Estados Unidos	83
13	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	83
1	Brensocatib, 1 Year Later: Who Benefits Most? \| Mark Metersky, MD	HCPLive @hcplivenews	98	Estados Unidos	94
4	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	82	Estados Unidos	84
8	Avapritinib's 4-Year Impact on Quality of Life in ISM \| Thanai Pongdee, MD	HCPLive @hcplivenews	73	Estados Unidos	84
15	FDA Expansion of Linaclotide for Children 2-5 Years With Functional Constipation	HCPLive @hcplivenews	63	Estados Unidos	83
18	Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More \| EAC 2026	HCPLive @hcplivenews	58	Estados Unidos	83
17	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	83
16	Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients \| ATS 2026 \| Gerald Criner, MD	HCPLive @hcplivenews	29	Estados Unidos	83
20	Ersodetug Shows Target Engagement but Misses Primary Endpoints in Phase 3 cHI Study	HCPLive @hcplivenews	20	Estados Unidos	83